MedPath

Acetic Acid

0.25% Acetic Acid Irrigation, USPin Plastic Pour Bottle

Approved
Approval ID

41bc12af-fac5-4ac1-b907-dcb3e35a054c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 2, 2018

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acetic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0338-0656
Application NumberNDA018523
Product Classification
M
Marketing Category
C73594
G
Generic Name
Acetic Acid
Product Specifications
Route of AdministrationIRRIGATION
Effective DateApril 15, 2015
FDA Product Classification

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
ACETIC ACIDActive
Quantity: 250 mg in 100 mL
Code: Q40Q9N063P
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 2/2/2018

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL

Acetic Acid Representative Container Label  NDC 0338-0656-04

Container Label

Not for Injection 2F7184
NDC 0338-0656-04

0.25% Acetic Acid
Irrigation, USP

1000 mL

Each 100 mL contains: 250 mg Glacial Acetic
Acid, USP. No antimicrobial agent has been
added. pH 3.0 (2.8 to 3.4). Osmolarity 42
mOsmol/L (calc.). Sterile, nonpyrogenic. Pour
Bottle.Hypotonic solution for irrigation only.
****Dosage and Administration: As directed by a
physician. See directions. Cautions: Warm
in oven to not more than 50°C for a maximum
of 60 days. Discard after 60 days of warming.
Do not use unless solution is clear and seal
is intact. Discard unused portion. Rx only.
Recommended storage: Room temperature
(25°C). Avoid excessive heat. See insert.

PL 325 plastic

Baxter Logo****
Baxter Healthcare Corporation
Deerfield, IL 60015 USA

Made in USA

LOT
EXP

07-09-00-0251

FPO
(91)0709000251
Bar Code

Bar Code Posit ion Only*
(01) 00303380656042

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 5/11/2006

INDICATIONS AND USAGE

0.25% Acetic Acid Irrigation, USP, is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. It also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 5/11/2006

CONTRAINDICATIONS

None known

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 5/11/2006

ADVERSE REACTIONS

Systemic acidosis, pain and hematuria have been reported in patients receiving urinary bladder irrigation with 0.25% Acetic Acid Irrigation, USP.

Should adverse reactions occur, discontinue the irrigation and reevaluate the clinical status of the patient.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 5/11/2006

DESCRIPTION

0.25% Acetic Acid Irrigation, USP, is a sterile, nonpyrogenic hypotonic solution for irrigation of the urinary bladder. Each 100 mL contains 250 mg Glacial Acetic Acid, USP, (CH3COOH) in Water for Injection, USP. pH 3.0 (2.8 to 3.4). Osmolarity: 42 mOsmol/L (calc.). No antimicrobial agent has been added.

The container is made from specially formulated polyolefin (PL 325). The polyolefin is a copolymer of ethylene and propylene. It contains no plasticizers or other mobile additives. As a result, the container has virtually no extractability or leachability. The total extractables after two years of storage being less than 0.01 ppm. It is also relatively impermeable to water vapor transmission and, therefore, requires no vapor barrier to maintain the proper drug concentration.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 5/11/2006

CLINICAL PHARMACOLOGY

The minimal amount of acetic acid which may enter the systemic circulation is readily metabolized.

WARNINGS SECTION

LOINC: 34071-1Updated: 5/11/2006

WARNINGS

Not for injection.

Use of this solution in patients with mucosal lesions of the urinary bladder may be harmful due to irritation of the lesion. Absorption via open lesions of the bladder mucosa may result in systemic acidosis.

The contents of an opened container should be used promptly to minimize the possibility of bacterial growth or pyrogen formation. Discard the unused portion of irrigating solution since no antimicrobial agent has been added.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 5/11/2006

DOSAGE AND ADMINISTRATION

The volume of solution needed will vary with nature and duration of the urologic procedure, according to physician’s instructions.

Irrigation drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 2/2/2018

Baxter Healthcare Corporation
Deerfield, IL 60015 USA

Printed in USA

Baxter is a registered trademark of Baxter International Inc.

07-19-00-0228

Rev. February 2018

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 2/2/2018

PRECAUTIONS

Pregnancy

Teratogenic Effects

Animal reproduction studies have not been conducted with 0.25% Acetic Acid Irrigation, USP. It is also not known whether 0.25% Acetic Acid Irrigation, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 0.25% Acetic Acid Irrigation, USP should be given to a pregnant woman only if clearly needed.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Warm in oven to not more than 50°C for a maximum of 60 days. Discard after 60 days of warming.

Do not administer unless the solution is clear and the seal is intact.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 2/2/2018

HOW SUPPLIED

0.25% Acetic Acid Irrigation, USP is supplied in a plastic pour bottle as follows:

2F7184

1000 mL

NDC 0338-0656-04

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended that the product be stored at room temperature (25°C): brief exposure up to 40ºC does not adversely affect the product.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.